Vifor Pharma
VIFN.SW
$179.34
Share price
0.48%
Change (1 day)
0.59%
Change (1 year)
Categories
P/S ratio for Vifor Pharma (VIFN.SW)
P/S ratio at the end of 2021: 5.77
According to Vifor Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.82768. At the end of 2021 the company had a P/S ratio of 5.77.
P/S ratio history for Vifor Pharma from 2005 to 2021
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2021 | 5.77 | 9.11% |
| 2020 | 5.29 | -13.44% |
| 2019 | 6.11 | 39.59% |
| 2018 | 4.37 | -27.06% |
| 2017 | 6.00 | 231.36% |
| 2016 | 1.81 | -32.69% |
| 2015 | 2.69 | 79.04% |
| 2014 | 1.50 | -13.29% |
| 2013 | 1.73 | 65.96% |
| 2012 | 1.04 | -6.39% |
| 2011 | 1.11 | -5.49% |
| 2010 | 1.18 | 58.98% |
| 2009 | 0.7419 | 4.57% |
| 2008 | 0.7095 | -44% |
| 2007 | 1.27 | 23.28% |
| 2006 | 1.03 | 40.6% |
| 2005 | 0.7310 |